1. Home
  2. ATON vs IMRN Comparison

ATON vs IMRN Comparison

Compare ATON & IMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AlphaTON Capital Corp. Common Stock

ATON

AlphaTON Capital Corp. Common Stock

N/A

Current Price

$1.46

Market Cap

12.6M

Sector

Energy

ML Signal

N/A

Logo Immuron Limited

IMRN

Immuron Limited

HOLD

Current Price

$1.11

Market Cap

12.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATON
IMRN
Founded
1973
1994
Country
British Virgin Islands
Australia
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.6M
12.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ATON
IMRN
Price
$1.46
$1.11
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.2M
1.2M
Earning Date
11-28-2025
08-29-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$4,777,422.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
48.63
52 Week Low
$1.41
$1.05
52 Week High
$15.82
$2.48

Technical Indicators

Market Signals
Indicator
ATON
IMRN
Relative Strength Index (RSI) N/A 28.95
Support Level N/A $1.42
Resistance Level N/A $1.78
Average True Range (ATR) 0.00 0.14
MACD 0.00 -0.03
Stochastic Oscillator 0.00 9.59

Price Performance

Historical Comparison
ATON
IMRN

About ATON AlphaTON Capital Corp. Common Stock

AlphaTON Capital Corp is a specialized digital asset treasury company focused on building and managing a strategic reserve of TON tokens and developing the Telegram ecosystem. The company implements a comprehensive treasury strategy that combines direct token acquisition, validator operations, and strategic ecosystem investments to generate sustainable returns for shareholders. Through its operations, it provides public market investors with institutional-grade exposure to the TON ecosystem and Telegram's billion user platform.

About IMRN Immuron Limited

Immuron Ltd is a commercial and clinical-stage biopharmaceutical company with a proprietary technology platform focused on polyclonal antibodies that can address unmet medical needs. The company's commercial products are: Travelan (an orally administered passive product indicated to reduce the risk of travelers' diarrhea and minor gastrointestinal disorders), and Protectyn, which is marketed as an immune supplement. Additionally, it has two clinical products in development, IMM124-E and IMM529, for the treatment of multiple high-value enteric disease indications. The firm has two reportable segments: Hyper-immune products, which derive maximum revenue, and Research and development. Geographically, the company generates maximum revenue from Australia, followed by the USA and Canada.

Share on Social Networks: